LeMaitre Vascular (LMAT) stock: analyst price target and their real reliability
Live quote · data updated Aug 28, 2026
LeMaitre Vascular · Health Care · ref. ETF XLV · 53 calls · price $79.67
What the company does: LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific.
📈 LeMaitre Vascular (LMAT) stock price
$79.67-16.4% over range
Aug 28, 25low $78.97 · high $117.39Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
67% recommend buying · 3 analysts
📊 JPI status : LeMaitre Vascular is no longer in our current JPI rankings, but appeared in the past (2015) — its upside may be behind it. See the stocks picked in 2015 →
🎯 LMAT price target & analyst consensus — price $79.67
The price target · all analysts combined (3 targets)
Highest target · 1 firm of 3$127+59.4%
Median target · of 3 targets$120+50.6%
Lowest target · 1 firm of 3$94+18.0%
Current price$79.67
⭐ What the most reliable analysts say
No reliable analyst is bullish on this stock right now. A “reliable” analyst is a firm that, on this sector, hits more than 55% of its targets and beats its sector. None of them sees upside here — which is exactly why this stock is in no JPI selection.
The consensus · 3 ratings (last 6 months)
Strong Buy00%
Buy267%
Hold133%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 LMAT price target all
All 53 calls, one by one, with our verdict on each firm.
→ See all 53 targets, analyst by analyst💡 The best analysts on LMAT most reliable
Their real reliability on LMAT, firm by firm: who was right, who was wrong.
→ See their reliability on LMATAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about LeMaitre Vascular? The JPI assistant answers using our backtest data.
🔎 Detailed analyses
✅ Historical analyst reliability on LMAT
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Sidoti & Co. | 100% | +101.1% | 2 |
| Canaccord Genuity ↗ | 100% | +74.2% | 4 |
| Stifel ↗ | 100% | +37.9% | 2 |
| JMP Securities | 100% | +33.5% | 3 |
| Roth Capital | 100% | +32.6% | 3 |
| Brean Capital | 100% | +28.8% | 2 |
| Barrington Research ↗ | 82% | +13.3% | 11 |
| Oppenheimer ↗ | 50% | +22.9% | 2 |
| First Analysis | 50% | +11.9% | 4 |
| Lake Street | 50% | +9.7% | 4 |
📊 What $1,000 invested in LeMaitre Vascular would be worth › open the full page
In short — $1,000 invested in LeMaitre Vascular 10 years ago would be worth $5,673 today, i.e. +19%/yr on average. Best year: 2024 (+62%), worst: 2018 (-26%). Price performance, excluding dividends.
If I'd invested $1,000 in LeMaitre Vascular
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $1,062 | +6% |
| 3 years ago | $2,126 | +113% |
| 5 years ago | $2,416 | +142% |
Return by year (LeMaitre Vascular)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | +21% | $1,207 (+21%) |
| 2025 | -12% | $1,062 (+6%) |
| 2024 | +62% | $1,724 (+72%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on LeMaitre Vascular
Loading news…
📋 All analyst calls on LMAT
Filtered on — · ✕ show all
Wells Fargo ↗
Aug 5, 26
■ Equal-Weight neutral · not a buy · 🎯$94
Price at call : $80.82 — gap to target +16%
Today : $79.67 — gap to target +18%
🎯 on LMAT : no call matured yet · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Aug 5, 27
matures : Aug 5, 27
Barrington Research ↗
Jun 3, 26
▲ Outperform · 🎯$120
Price at call : $93.56 — upside +28%
Today : $79.67 — upside +51%
🎯 on LMAT : 82% (11 calls matureds) · 📊 on Health : 35.1% · -4.0% (57 calls)
in progress (365j)
matures : Jun 3, 27
matures : Jun 3, 27
Barrington Research ↗
May 7, 26
▲ Outperform · 🎯$120
Price at call : $107.91 — upside +11%
Today : $79.67 — upside +51%
🎯 on LMAT : 82% (11 calls matureds) · 📊 on Health : 35.1% · -4.0% (57 calls)
in progress (365j)
matures : May 7, 27
matures : May 7, 27
Citizens
May 6, 26
▲ Market Outperform · 🎯$127
Price at call : $107.91 — upside +18%
Today : $79.67 — upside +59%
🎯 on LMAT : no call matured yet · 📊 unranked overall
in progress (365j)
matures : May 6, 27
matures : May 6, 27
Wells Fargo ↗
May 6, 26
■ Equal-Weight neutral · not a buy · 🎯$104
Price at call : $107.91 — gap to target -4%
Today : $79.67 — gap to target +31%
🎯 on LMAT : no call matured yet · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : May 6, 27
matures : May 6, 27
Barrington Research ↗
Feb 26, 26
▲ Outperform · 🎯$105
Price at call : $108.18 — upside -3%
Today : $79.67 — upside +32%
🎯 on LMAT : 82% (11 calls matureds) · 📊 on Health : 35.1% · -4.0% (57 calls)
in progress (365j)
matures : Feb 26, 27
matures : Feb 26, 27
Roth Capital
Feb 26, 26
▲ Buy · 🎯$117
Price at call : $108.18 — upside +8%
Today : $79.67 — upside +47%
🎯 on LMAT : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Feb 26, 27
matures : Feb 26, 27
Wells Fargo ↗
Feb 26, 26
■ Equal-Weight neutral · not a buy · 🎯$94
Price at call : $108.18 — gap to target -13%
Today : $79.67 — gap to target +18%
🎯 on LMAT : no call matured yet · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Feb 26, 27
matures : Feb 26, 27
See the other 45 calls, newest to oldest
Citizens
Feb 26, 26
▲ Market Outperform · 🎯$118
Price at call : $108.18 — upside +9%
Today : $79.67 — upside +48%
🎯 on LMAT : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Feb 26, 27
matures : Feb 26, 27
Barrington Research ↗
Feb 20, 26
▲ Outperform · 🎯$95
Price at call : $92.94 — upside +2%
Today : $79.67 — upside +19%
🎯 on LMAT : 82% (11 calls matureds) · 📊 on Health : 35.1% · -4.0% (57 calls)
in progress (365j)
matures : Feb 20, 27
matures : Feb 20, 27
Wells Fargo ↗
Nov 7, 25
■ Equal-Weight neutral · not a buy · 🎯$93
Price at call : $87.79 — gap to target +6%
Today : $79.67 — gap to target +17%
🎯 on LMAT : no call matured yet · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Nov 7, 26
matures : Nov 7, 26
Barrington Research ↗
Oct 15, 25
▲ Outperform · 🎯$95
Price at call : $87.26 — upside +9%
Today : $79.67 — upside +19%
🎯 on LMAT : 82% (11 calls matureds) · 📊 on Health : 35.1% · -4.0% (57 calls)
in progress (365j)
matures : Oct 15, 26
matures : Oct 15, 26
Barrington Research ↗
Sep 23, 25
▲ Outperform · 🎯$95
Price at call : $87.8 — upside +8%
Today : $79.67 — upside +19%
🎯 on LMAT : 82% (11 calls matureds) · 📊 on Health : 35.1% · -4.0% (57 calls)
in progress (365j)
matures : Sep 23, 26
matures : Sep 23, 26
Cantor Fitzgerald ↗
Aug 6, 25
■ Neutral neutral · not a buy · 🎯$95
Price at call : $94.26 — gap to target +1%
Today : $79.67 — gap to target +19%
🎯 on LMAT : no call matured yet · 📊 on Health : 50.6% · +13.8% (166 calls)
in progress (365j)
matures : Aug 6, 26
matures : Aug 6, 26
Barrington Research ↗
Aug 6, 25
▲ Outperform · 🎯$95
Price at call : $93.23 — upside +2%
Today : $79.67 — upside +19%
Expected +2% · Actual -13% · Reason (≥ +15%) : ✗ No
🎯 on LMAT : 82% (11 calls matureds) · 📊 on Health : 35.1% · -4.0% (57 calls)
-13.3%
stock -13% · XLV +26%
matured Aug 6, 26
Barrington Research ↗
Jul 22, 25
■ Market Perform neutral · not a buy
🎯 on LMAT : 82% (11 calls matureds) · 📊 on Health : 35.1% · -4.0% (57 calls)
in progress (365j)
matures : Jul 22, 26
matures : Jul 22, 26
Lake Street
Feb 28, 25
▲ Buy · 🎯$110
Price at call : $92.16 — upside +19%
Today : $79.67 — upside +38%
Expected +19% · Actual +17% · Reason (≥ +15%) : ✓ Yes
🎯 on LMAT : 67% (3 calls matureds) · 📊 on Health : 61.5% · +24.8% (26 calls)
+16.5%
stock +17% · XLV +6%
matured Feb 28, 26
Citizens Capital Markets
Feb 28, 25
▲ Buy · 🎯$110
Price at call : $92.16 — upside +19%
Today : $79.67 — upside +38%
Expected +19% · Actual +17% · Reason (≥ +15%) : ✓ Yes
🎯 on LMAT : 100% (1 call matured) · 📊 unranked overall
+16.5%
stock +17% · XLV +6%
matured Feb 28, 26
Barrington Research ↗
Feb 28, 25
■ Market Perform neutral · not a buy
🎯 on LMAT : 82% (11 calls matureds) · 📊 on Health : 35.1% · -4.0% (57 calls)
in progress (365j)
matures : Feb 28, 26
matures : Feb 28, 26
Wells Fargo ↗
Feb 13, 25
■ Equal-Weight neutral · not a buy · 🎯$95
Price at call : $98.65 — gap to target -4%
Today : $79.67 — gap to target +19%
🎯 on LMAT : no call matured yet · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Feb 13, 26
matures : Feb 13, 26
Oppenheimer ↗
Nov 1, 24
▲ Outperform · 🎯$93
Price at call : $96.35 — upside -3%
Today : $79.67 — upside +17%
Expected -3% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on LMAT : 50% (2 calls matureds) · 📊 on Health : 47.3% · +6.3% (93 calls)
-9.8%
stock -10% · XLV -2%
matured Nov 1, 25
Barrington Research ↗
Nov 1, 24
▲ Outperform · 🎯$93
Price at call : $96.35 — upside -3%
Today : $79.67 — upside +17%
Expected -3% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on LMAT : 82% (11 calls matureds) · 📊 on Health : 35.1% · -4.0% (57 calls)
-9.8%
stock -10% · XLV -2%
matured Nov 1, 25
Cantor Fitzgerald ↗
Oct 15, 24
■ Neutral neutral · not a buy · 🎯$96
Price at call : $91.24 — gap to target +5%
Today : $79.67 — gap to target +20%
🎯 on LMAT : no call matured yet · 📊 on Health : 50.6% · +13.8% (166 calls)
in progress (365j)
matures : Oct 15, 25
matures : Oct 15, 25
Barrington Research ↗
Sep 20, 24
▲ Outperform · 🎯$92
Price at call : $91.41 — upside +1%
Today : $79.67 — upside +15%
Expected +1% · Actual +1% · Reason (≥ +15%) : ✗ No
🎯 on LMAT : 82% (11 calls matureds) · 📊 on Health : 35.1% · -4.0% (57 calls)
+1.0%
stock +1% · XLV -12%
matured Sep 20, 25
JMP Securities
Aug 20, 24
▲ Market Outperform · 🎯$100
Price at call : $85.36 — upside +17%
Today : $79.67 — upside +26%
Expected +17% · Actual +13% · Reason (≥ +15%) : ✗ No
🎯 on LMAT : 100% (3 calls matureds) · 📊 unranked overall
+13.3%
stock +13% · XLV -11%
matured Aug 20, 25
Barrington Research ↗
Aug 3, 24
▲ Outperform · 🎯$92
Price at call : $80.47 — upside +14%
Today : $79.67 — upside +15%
Expected +14% · Actual +5% · Reason (≥ +15%) : ✗ No
🎯 on LMAT : 82% (11 calls matureds) · 📊 on Health : 35.1% · -4.0% (57 calls)
+4.8%
stock +5% · XLV -9%
matured Aug 3, 25
Barrington Research ↗
May 3, 24
▲ Outperform · 🎯$79
Price at call : $75 — upside +5%
Today : $79.67 — upside -1%
Expected +5% · Actual +7% · Reason (≥ +15%) : ✗ No
🎯 on LMAT : 82% (11 calls matureds) · 📊 on Health : 35.1% · -4.0% (57 calls)
+7.2%
stock +7% · XLV -2%
matured May 3, 25
JMP Securities
May 3, 24
▲ Market Outperform · 🎯$77
Price at call : $75 — upside +3%
Today : $79.67 — upside -3%
Expected +3% · Actual +7% · Reason (≥ +15%) : ✗ No
🎯 on LMAT : 100% (3 calls matureds) · 📊 unranked overall
+7.2%
stock +7% · XLV -2%
matured May 3, 25
▲ Buy · 🎯$75
Price at call : $65.46 — upside +15%
Today : $79.67 — upside -6%
Expected +15% · Actual +40% · Reason (≥ +15%) : ✓ Yes
🎯 on LMAT : 100% (1 call matured) · 📊 on Health : 44.8% · +6.7% (96 calls)
+39.8%
stock +40% · XLV -1%
matured Apr 26, 25
Barrington Research ↗
Feb 28, 24
▲ Outperform · 🎯$69
Price at call : $70 — upside -1%
Today : $79.67 — upside -13%
Expected -1% · Actual +31% · Reason (≥ +15%) : ✓ Yes
🎯 on LMAT : 82% (11 calls matureds) · 📊 on Health : 35.1% · -4.0% (57 calls)
+31.2%
stock +31% · XLV +3%
matured Feb 27, 25
■ Sector Weight neutral · not a buy
🎯 on LMAT : no call matured yet · 📊 on Health : 25.2% · -18.3% (107 calls)
in progress (365j)
matures : Feb 5, 25
matures : Feb 5, 25
JMP Securities
Oct 23, 23
▲ Market Outperform · 🎯$60
Price at call : $48.46 — upside +24%
Today : $79.67 — upside -25%
Expected +24% · Actual +80% · Reason (≥ +15%) : ✓ Yes
🎯 on LMAT : 100% (3 calls matureds) · 📊 unranked overall
+80.1%
stock +80% · XLV +19%
matured Oct 22, 24
Oppenheimer ↗
Sep 6, 23
▲ Outperform · 🎯$70
Price at call : $56.65 — upside +24%
Today : $79.67 — upside -12%
Expected +24% · Actual +56% · Reason (≥ +15%) : ✓ Yes
🎯 on LMAT : 50% (2 calls matureds) · 📊 on Health : 47.3% · +6.3% (93 calls)
+55.5%
stock +56% · XLV +18%
matured Sep 5, 24
■ Hold neutral · not a buy · 🎯$67
Price at call : $57.22 — gap to target +17%
Today : $79.67 — gap to target -16%
🎯 on LMAT : 0% (1 call matured) · 📊 on Health : 50% · +9.9% (136 calls)
in progress (365j)
matures : Aug 2, 24
matures : Aug 2, 24
Lake Street
Aug 2, 23
▲ Buy · 🎯$75
Price at call : $57.22 — upside +31%
Today : $79.67 — upside -6%
Expected +31% · Actual +49% · Reason (≥ +15%) : ✓ Yes
🎯 on LMAT : 67% (3 calls matureds) · 📊 on Health : 61.5% · +24.8% (26 calls)
+48.6%
stock +49% · XLV +14%
matured Aug 1, 24
Barrington Research ↗
Aug 2, 23
▲ Outperform · 🎯$66
Price at call : $64.7 — upside +2%
Today : $79.67 — upside -17%
Expected +2% · Actual +33% · Reason (≥ +15%) : ✓ Yes
🎯 on LMAT : 82% (11 calls matureds) · 📊 on Health : 35.1% · -4.0% (57 calls)
+33.3%
stock +33% · XLV +13%
matured Aug 1, 24
Barrington Research ↗
May 3, 23
▲ Outperform · 🎯$62
Price at call : $65.23 — upside -5%
Today : $79.67 — upside -22%
Expected -5% · Actual +14% · Reason (≥ +15%) : ✗ No
🎯 on LMAT : 82% (11 calls matureds) · 📊 on Health : 35.1% · -4.0% (57 calls)
+13.8%
stock +14% · XLV +6%
matured May 2, 24
Barrington Research ↗
Oct 28, 22
■ Market Perform neutral · not a buy
🎯 on LMAT : 82% (11 calls matureds) · 📊 on Health : 35.1% · -4.0% (57 calls)
in progress (365j)
matures : Oct 28, 23
matures : Oct 28, 23
▲ Buy · 🎯$70
Price at call : $58.15 — upside +20%
Today : $79.67 — upside -12%
Expected +20% · Actual -15% · Reason (≥ +15%) : ✗ No
🎯 on LMAT : 0% (1 call matured) · 📊 on Health : 50% · +9.9% (136 calls)
-15.0%
stock -15% · XLV -4%
matured Sep 16, 22
Roth Capital
Aug 3, 21
■ Neutral neutral · not a buy · 🎯$58
Price at call : $55.95 — gap to target +4%
Today : $79.67 — gap to target -27%
🎯 on LMAT : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Aug 3, 22
matures : Aug 3, 22
Roth Capital
May 4, 21
■ Neutral neutral · not a buy · 🎯$55
Price at call : $51.32 — gap to target +7%
Today : $79.67 — gap to target -31%
🎯 on LMAT : no call matured yet · 📊 unranked overall
in progress (365j)
matures : May 4, 22
matures : May 4, 22
■ Sector Weight neutral · not a buy
🎯 on LMAT : no call matured yet · 📊 on Health : 25.2% · -18.3% (107 calls)
in progress (365j)
matures : Feb 12, 22
matures : Feb 12, 22
Roth Capital
Oct 30, 20
■ Neutral neutral · not a buy · 🎯$36
Price at call : $33.98 — gap to target +6%
Today : $79.67 — gap to target -55%
🎯 on LMAT : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Oct 30, 21
matures : Oct 30, 21
■ Hold neutral · not a buy · 🎯$30
Price at call : $29.98 — gap to target +0%
Today : $79.67 — gap to target -62%
🎯 on LMAT : 100% (1 call matured) · 📊 on Health : 44.8% · +6.7% (96 calls)
in progress (365j)
matures : Jul 24, 21
matures : Jul 24, 21
Canaccord Genuity ↗
Jul 24, 20
■ Hold neutral · not a buy · 🎯$30
Price at call : $29.98 — gap to target +0%
Today : $79.67 — gap to target -62%
🎯 on LMAT : no call matured yet · 📊 on Health : 38.9% · -0.9% (144 calls)
in progress (365j)
matures : Jul 24, 21
matures : Jul 24, 21
■ Hold neutral · not a buy · 🎯$25
Price at call : $25.28 — gap to target -1%
Today : $79.67 — gap to target -69%
🎯 on LMAT : 100% (1 call matured) · 📊 on Health : 44.8% · +6.7% (96 calls)
in progress (365j)
matures : May 4, 21
matures : May 4, 21
Canaccord Genuity ↗
Apr 14, 20
■ Hold neutral · not a buy · 🎯$24
Price at call : $26.86 — gap to target -11%
Today : $79.67 — gap to target -70%
🎯 on LMAT : no call matured yet · 📊 on Health : 38.9% · -0.9% (144 calls)
in progress (365j)
matures : Apr 14, 21
matures : Apr 14, 21
Sidoti & Co.
Apr 8, 20
▲ Buy · 🎯$34
Price at call : $25.81 — upside +32%
Today : $79.67 — upside -57%
Expected +32% · Actual +95% · Reason (≥ +15%) : ✓ Yes
🎯 on LMAT : 100% (2 calls matureds) · 📊 on Health : 54.2% · +25.8% (24 calls)
+95.2%
stock +95% · XLV +24%
matured Apr 8, 21
Sidoti & Co.
Mar 16, 20
▲ Buy · 🎯$38
Price at call : $22.08 — upside +72%
Today : $79.67 — upside -52%
Expected +72% · Actual +107% · Reason (≥ +15%) : ✓ Yes
🎯 on LMAT : 100% (2 calls matureds) · 📊 on Health : 54.2% · +25.8% (24 calls)
+106.9%
stock +107% · XLV +41%
matured Mar 16, 21
Lake Street
Oct 24, 19
▲ Buy · 🎯$40
Price at call : $34.37 — upside +16%
Today : $79.67 — upside -50%
Expected +16% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on LMAT : 67% (3 calls matureds) · 📊 on Health : 61.5% · +24.8% (26 calls)
-4.5%
stock -5% · XLV +17%
matured Oct 23, 20
Barrington Research ↗
Aug 1, 13
▲ Outperform · 🎯$8.5
Price at call : $6.8 — upside +25%
Today : $79.67 — upside -89%
Expected +25% · Actual +18% · Reason (≥ +15%) : ✓ Yes
🎯 on LMAT : 82% (11 calls matureds) · 📊 on Health : 35.1% · -4.0% (57 calls)
+17.6%
stock +18% · XLV +19%
matured Aug 1, 14
Barrington Research ↗
Nov 2, 12
▲ Outperform · 🎯$7.5
Price at call : $6.32 — upside +19%
Today : $79.67 — upside -91%
Expected +19% · Actual +31% · Reason (≥ +15%) : ✓ Yes
🎯 on LMAT : 82% (11 calls matureds) · 📊 on Health : 35.1% · -4.0% (57 calls)
+31.2%
stock +31% · XLV +32%
matured Nov 2, 13
Barrington Research ↗
Nov 2, 12
▲ Outperform · 🎯$7.5
Price at call : $6.39 — upside +17%
Today : $79.67 — upside -91%
Expected +17% · Actual +30% · Reason (≥ +15%) : ✓ Yes
🎯 on LMAT : 82% (11 calls matureds) · 📊 on Health : 35.1% · -4.0% (57 calls)
+29.7%
stock +30% · XLV +32%
matured Nov 2, 13
Frequently asked questions
Should I buy LeMaitre Vascular stock?
This isn't buy advice. For LeMaitre Vascular, the analyst consensus is "Buy", with an average price target of $120 (+51% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (2 calls tracked on LeMaitre Vascular). We show the numbers — you decide.
Is it too late to buy LeMaitre Vascular? How high can it go?
The most bullish analyst target on LeMaitre Vascular is $127 (+59% above today's price); the average is $120. That's the upside they see. Check how reliable those analysts have actually been on LeMaitre Vascular on our site before trusting it.
Is LeMaitre Vascular still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 11 analysts have a real record on LeMaitre Vascular, the best hitting 100% over 2 calls. Current consensus: "Buy". Make your call on data, not noise.
What has LeMaitre Vascular's past performance been?
Historical returns and a "how much if I had invested" calculator: LMAT performance & returns.
BIIB 
VRTX 
UNH 
REGN 
EW 
SRPT 
VEEV 
BSX